Return to search
News and Analysis

Stealth Biotherapeutics Corp lands $20m

Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement.

By
Iris Dorbian
-

Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement. The investor was Morningside.

Source: Press Release